Strides Pharma Science Limited (STAR.NS)
INR 634.75
(-2.33%)
INR 634.75
(-2.33%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 14.38 Billion INR | -30.21% |
| 2022 | 20.61 Billion INR | 43.28% |
| 2021 | 14.38 Billion INR | -21.91% |
| 2020 | 18.42 Billion INR | 25.1% |
| 2019 | 14.72 Billion INR | 2.29% |
| 2018 | 14.39 Billion INR | 4.93% |
| 2017 | 13.72 Billion INR | -24.32% |
| 2016 | 18.12 Billion INR | 20.83% |
| 2015 | 15 Billion INR | 162.51% |
| 2014 | 5.71 Billion INR | 24.88% |
| 2013 | 4.57 Billion INR | -62.07% |
| 2012 | 12.06 Billion INR | 15.1% |
| 2011 | 10.48 Billion INR | 28.23% |
| 2010 | 8.17 Billion INR | 49.1% |
| 2009 | 5.48 Billion INR | 26.44% |
| 2008 | 4.33 Billion INR | 40.8% |
| 2007 | 3.07 Billion INR | -14.08% |
| 2006 | 3.58 Billion INR | 26.64% |
| 2005 | 2.82 Billion INR | 27.79% |
| 2004 | 2.21 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 4.06 Billion INR | -3.0% |
| 2024 Q2 | 7.03 Billion INR | 6.63% |
| 2023 FY | 14.38 Billion INR | -30.21% |
| 2023 Q4 | 4.18 Billion INR | -32.05% |
| 2023 Q3 | 6.16 Billion INR | 6.04% |
| 2023 Q2 | 5.81 Billion INR | 6.66% |
| 2023 Q1 | 5.45 Billion INR | -6.94% |
| 2022 FY | 20.61 Billion INR | 43.28% |
| 2022 Q2 | 5.1 Billion INR | 8.87% |
| 2022 Q4 | 5.85 Billion INR | 17.76% |
| 2022 Q3 | 4.97 Billion INR | -2.48% |
| 2022 Q1 | 4.68 Billion INR | 51.42% |
| 2021 Q3 | 3.93 Billion INR | -0.89% |
| 2021 Q1 | 3.39 Billion INR | -14.38% |
| 2021 FY | 14.38 Billion INR | -21.91% |
| 2021 Q2 | 3.96 Billion INR | 16.95% |
| 2021 Q4 | 3.09 Billion INR | -21.34% |
| 2020 Q2 | 4.85 Billion INR | 1.16% |
| 2020 Q3 | 4.81 Billion INR | -0.76% |
| 2020 Q4 | 3.96 Billion INR | -17.69% |
| 2020 Q1 | 4.79 Billion INR | 122.77% |
| 2020 FY | 18.42 Billion INR | 25.1% |
| 2019 Q1 | 3.69 Billion INR | 13.97% |
| 2019 FY | 14.72 Billion INR | 2.29% |
| 2019 Q4 | 2.15 Billion INR | -54.33% |
| 2019 Q3 | 4.71 Billion INR | 13.26% |
| 2019 Q2 | 4.16 Billion INR | 12.5% |
| 2018 Q3 | 4.11 Billion INR | 8.25% |
| 2018 Q2 | 3.8 Billion INR | 17.76% |
| 2018 Q1 | 3.23 Billion INR | -13.02% |
| 2018 FY | 14.39 Billion INR | 4.93% |
| 2018 Q4 | 3.24 Billion INR | -21.17% |
| 2017 FY | 13.72 Billion INR | -24.32% |
| 2017 Q4 | 3.71 Billion INR | -7.04% |
| 2017 Q3 | 3.99 Billion INR | -21.96% |
| 2017 Q2 | 5.11 Billion INR | 21.17% |
| 2017 Q1 | 4.22 Billion INR | -16.19% |
| 2016 Q1 | 4.44 Billion INR | 1.11% |
| 2016 Q4 | 5.04 Billion INR | 6.3% |
| 2016 Q3 | 4.74 Billion INR | -9.16% |
| 2016 Q2 | 5.22 Billion INR | 17.43% |
| 2016 FY | 18.12 Billion INR | 20.83% |
| 2015 Q2 | 1.73 Billion INR | -37.46% |
| 2015 Q1 | 2.78 Billion INR | 69.43% |
| 2015 FY | 15 Billion INR | 162.51% |
| 2015 Q4 | 4.39 Billion INR | -38.38% |
| 2015 Q3 | 7.13 Billion INR | 310.12% |
| 2014 Q3 | 1.54 Billion INR | 14.4% |
| 2014 Q2 | 1.34 Billion INR | 14.26% |
| 2014 Q1 | 1.18 Billion INR | 0.0% |
| 2014 FY | 5.71 Billion INR | 24.88% |
| 2014 Q4 | 1.64 Billion INR | 6.36% |
| 2013 FY | 4.57 Billion INR | -62.07% |
| 2012 FY | 12.06 Billion INR | 15.1% |
| 2011 FY | 10.48 Billion INR | 28.23% |
| 2010 FY | 8.17 Billion INR | 49.1% |
| 2009 FY | 5.48 Billion INR | 26.44% |
| 2008 FY | 4.33 Billion INR | 40.8% |
| 2007 FY | 3.07 Billion INR | -14.08% |
| 2006 FY | 3.58 Billion INR | 26.64% |
| 2005 FY | 2.82 Billion INR | 27.79% |
| 2004 FY | 2.21 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Amrutanjan Health Care Limited | 2.09 Billion INR | -587.099% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -114591.989% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -56.282% |
| FDC Limited | 6.58 Billion INR | -118.458% |
| Gufic Biosciences Limited | 4.07 Billion INR | -253.192% |
| Hikal Limited | 5.95 Billion INR | -141.492% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -248.109% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -204.891% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -2218.879% |
| Medico Remedies Limited | 262.14 Million INR | -5388.628% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -198.305% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -2619.17% |
| RPG Life Sciences Limited | 2.48 Billion INR | -479.465% |
| Sequent Scientific Limited | 2.97 Billion INR | -383.028% |
| Shilpa Medicare Limited | 3.56 Billion INR | -303.945% |
| Sigachi Industries Limited | 2 Billion INR | -618.585% |
| Themis Medicare Limited | 2.42 Billion INR | -494.548% |
| Unichem Laboratories Limited | 4.86 Billion INR | -195.752% |
| Venus Remedies Limited | 2.18 Billion INR | -559.223% |
| Wanbury Limited | 1.73 Billion INR | -731.374% |
| ZIM Laboratories Limited | 1.26 Billion INR | -1034.876% |
| Lupin Limited | 125.09 Billion INR | 88.498% |
| Innova Captab Limited | 3.46 Billion INR | -315.308% |
| Ind-Swift Limited | 2.17 Billion INR | -562.274% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -877.582% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 86.865% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 968.9% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -131.22% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -1981.634% |
| Morepen Laboratories Limited | 6.16 Billion INR | -133.525% |
| Laurus Labs Limited | 15.44 Billion INR | 6.865% |
| Aarti Drugs Limited | 8.31 Billion INR | -73.013% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -15.725% |
| Alembic Limited | 1 Billion INR | -1338.657% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 46.274% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 79.25% |
| Vaishali Pharma Limited | 90.32 Million INR | -15829.619% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -146.737% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -2104.77% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 26.752% |
| Eris Lifesciences Limited | 10.42 Billion INR | -37.992% |
| Windlas Biotech Limited | 1.33 Billion INR | -974.702% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 94.434% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -662.54% |
| Orchid Pharma Limited | 2.32 Billion INR | -520.096% |
| Albert David Limited | 1.4 Billion INR | -921.82% |
| Hester Biosciences Limited | 1.27 Billion INR | -1029.675% |
| Sakar Healthcare Limited | 699.58 Million INR | -1956.664% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -248.949% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -148.869% |
| Divi's Laboratories Limited | 32.44 Billion INR | 55.647% |
| Mankind Pharma Limited | 42.19 Billion INR | 65.903% |
| Neuland Laboratories Limited | 8.24 Billion INR | -74.447% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 5.707% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 88.509% |
| Wockhardt Limited | 7.72 Billion INR | -86.374% |
| Bal Pharma Limited | 770.19 Million INR | -1768.113% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 91.206% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -289.348% |
| Alkem Laboratories Limited | 52.29 Billion INR | 72.488% |
| Valiant Laboratories Limited | 138.02 Million INR | -10323.976% |
| Ajanta Pharma Limited | 21.06 Billion INR | 31.693% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -3082.133% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -12629.574% |
| Granules India Limited | 16.79 Billion INR | 14.353% |
| Medicamen Biotech Limited | 495.49 Million INR | -2803.785% |
| Ipca Laboratories Limited | 48.58 Billion INR | 70.385% |
| Brooks Laboratories Limited | 65.62 Million INR | -21826.41% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -2471.588% |
| Piramal Enterprises Limited | 8.04 Billion INR | -78.883% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 69.228% |
| NATCO Pharma Limited | 25.73 Billion INR | 44.093% |
| Suven Life Sciences Limited | -200.79 Million INR | 7265.5% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 13330.811% |
| Indoco Remedies Limited | 8.04 Billion INR | -78.89% |
| Alpa Laboratories Limited | 188.89 Million INR | -7516.988% |
| Lasa Supergenerics Limited | 121.02 Million INR | -11788.053% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -3579.202% |